Aurisco Pharmaceutical Co Ltd (605116) — Free Cash Flow Generation Index
Aurisco Pharmaceutical Co Ltd (605116) has a Free Cash Flow Generation Index of -0.63x as of December 2024. Free cash flow of CN¥-207.87 Million represents -1% of operating cash flow (CN¥332.41 Million). Read 605116 total liabilities for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Aurisco Pharmaceutical Co Ltd Free Cash Flow Generation Index (2017–2024)
Historical FCF Generation Index trend for Aurisco Pharmaceutical Co Ltd across 8 annual periods. Explore 605116 capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Aurisco Pharmaceutical Co Ltd (2017–2024)
Year-by-year Free Cash Flow Generation Index for Aurisco Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see Aurisco Pharmaceutical Co Ltd (605116) market capitalisation.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.63x | CN¥-207.87 Million | CN¥332.41 Million | CN¥540.28 Million | ▼ -400.9% |
| 2023 | 0.21x | CN¥80.13 Million | CN¥385.61 Million | CN¥305.48 Million | ▲ +169.4% |
| 2022 | -0.30x | CN¥-49.82 Million | CN¥166.41 Million | CN¥216.23 Million | ▼ -23.0% |
| 2021 | -0.24x | CN¥-49.04 Million | CN¥201.57 Million | CN¥250.61 Million | ▼ -193.7% |
| 2020 | 0.26x | CN¥55.68 Million | CN¥214.48 Million | CN¥158.80 Million | ▼ -56.5% |
| 2019 | 0.60x | CN¥107.43 Million | CN¥179.90 Million | CN¥72.47 Million | ▲ +319.5% |
| 2018 | 0.14x | CN¥15.63 Million | CN¥109.77 Million | CN¥94.14 Million | ▲ +48.4% |
| 2017 | 0.10x | CN¥11.31 Million | CN¥117.91 Million | CN¥106.60 Million | — |